Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: United States Clear all

380 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
20018
20028
200310
200410
200517
200616
200727
200818
200919
201014
201119
20128
201312
201414
201514
201616
201713
20183
201912
20209
202110
202215
20239
20247
202511
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed217
Terminated67
Recruiting47
Active, not recruiting28
Withdrawn11
Unknown status7
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)44
Duke University30
M.D. Anderson Cancer Center23
Memorial Sloan Kettering Cancer Center13
Wake Forest University Health Sciences9
Alliance for Clinical Trials in Oncology7
Case Comprehensive Cancer Center7
Children's Oncology Group6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
St. Jude Children's Research Hospital6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms380
Glioblastoma152
Glioma96
Gliosarcoma88
Astrocytoma76
Central Nervous System Neoplasms75
Oligodendroglioma54
Breast Neoplasms33
Melanoma31
Neoplasm Metastasis30

Trials

Showing 1 to 25 of 380. Each trial links to its page on Pharma Observatory.

280 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.